A new treatment method against peritoneal metastases in colon cancer from the Catharina Hospital Eindhoven and the Erasmus MC Rotterdam is working better than expected. This is evident from small-scale research that took place in both hospitals. Researchers call it a breakthrough.
Until now, Dutch patients with colon cancer and metastases in the peritoneum only received chemotherapy via an infusion into the bloodstream. But it often did not catch on enough. With the new INTERACT treatment, they now also receive chemotherapy directly into the abdominal cavity.
The average life expectancy of patients increases from six months without treatment to two years. Approximately 750 people are eligible per year. According to the doctors involved, there is a good chance that it will also work against metastases against other types of cancer.